Avenzo Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Avenzo Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001) (NCT07193511) | Avenzo Therapeutics, Inc. | 2025-10-02 |
| ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors (NCT06998407) | Avenzo Therapeutics, Inc. | 2025-08-20 |
| AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) (NCT07038343) | Avenzo Therapeutics, Inc. | 2025-06-04 |
| Study of AVZO-021 in Patients With Advanced Solid Tumors (NCT05867251) | Avenzo Therapeutics, Inc. | 2023-08-30 |
Track Avenzo Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.